(Reuters) - Britain's top share index ticked down early on Monday, after Barclays agreed to buy ABN AMRO for $91 billion and investors turned negative to a U.S. acquisition by AstraZeneca.
Barclays slipped 2.4 percent to top the FTSE 100 losers as traders said the UK bank was no longer a bid target after its takeover of ABN and the deal was fairly priced.
Read more at Reuters Africa
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment